Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-22-046973

Director bought 46,170 shares at an average $108.28 ($4,999,230)

From the SEC's structured data for this filing

Trades in this filing

Chambers Michael Andrew · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-08-19 Purchase : show line 1 in the form +40,110 $108.20 $4,339,902 45,018 D
2022-08-19 Purchase : show line 2 in the form +6,060 $108.80 $659,328 51,078 D
Open-market purchases · 46,170 sh · avg $108.28 · $4,999,230
Loading xslF345X03/doc4.xml…